Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPLACIZUMAB vs CARBIDOPA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPLACIZUMAB vs CARBIDOPA: Safety Overview

Metric CAPLACIZUMAB CARBIDOPA
Total FAERS Reports 145 302
Deaths Reported 34 41
Death Rate 23.4% 13.6%
Hospitalizations 53 122
Average Patient Age 53.0 yrs 71.3 yrs
% Female Patients 51.2% 44.3%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Genzyme Corporation Dr. Reddy's Laboratories Inc
Route N/A ORAL
Marketing Status N/A Prescription